Bank of New York Mellon’s Evoke Pharma EVOK Stock Holding History

Bank of New York Mellon’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-173	Closed	-$62K	–	4247
2018 Q2	$62K	Hold	173	–	–	﹤0.01%	4063
2018 Q1	$52K	Hold	173	–	–	﹤0.01%	4163
2017 Q4	$56K	Hold	173	–	–	﹤0.01%	4187
2017 Q3	$83K	Hold	173	–	–	﹤0.01%	4031
2017 Q2	$64K	Sell	173 -36	-17%	-$13.8K	﹤0.01%	4101
2017 Q1	$93K	Buy	209 +130	+165%	+$53.3K	﹤0.01%	4044
2016 Q4	$23K	Buy	+79	New	+$20.5K	﹤0.01%	4206
2016 Q3	–	Sell	-164	Closed	-$162K	–	4282
2016 Q2	$162K	Buy	164 +3	+2%	+$2.35K	﹤0.01%	3954
2016 Q1	$118K	Hold	161	–	–	﹤0.01%	3929
2015 Q4	$77K	Buy	+161	New	+$81.8K	﹤0.01%	4111

Other funds holding EVOK

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Bank of New York Mellon's EVOK Position: Q3 2018 in Review

Bank of New York Mellon sold out of Evoke Pharma (EVOK) in Q3 2018, closing a stake of 173 shares — an estimated $62K sold.

Bank of New York Mellon first reported a position in EVOK in Q4 2015 and held it in 10 quarters. The position peaked at $162K in Q2 2016. 21 funds tracked by Wall St. Rank hold EVOK as of Q3 2018.

Bank of New York Mellon reported no remaining Evoke Pharma position as of Q3 2018 after selling out during the quarter.
Bank of New York Mellon sold 173 Evoke Pharma shares in Q3 2018, an estimated $62K.
Bank of New York Mellon first reported a position in Evoke Pharma in Q4 2015 and held it in 10 quarters.
Bank of New York Mellon's Evoke Pharma position peaked at $162K in Q2 2016.
21 funds tracked by Wall St. Rank held Evoke Pharma as of Q3 2018.

Based on Bank of New York Mellon's 13F filing for Q3 2018, filed 9 Nov 2018.